Show simple item record

dc.contributor.authorBlankestijn, Peter J
dc.contributor.authorFischer, Kathrin I
dc.contributor.authorBarth, Claudia
dc.contributor.authorCromm, Krister
dc.contributor.authorCanaud, Bernard
dc.contributor.authorDavenport, Andrew
dc.contributor.authorGrobbee, Diederick E
dc.contributor.authorHegbrant, Jörgen
dc.contributor.authorRoes, Kit C
dc.contributor.authorRose, Matthias
dc.contributor.authorStrippoli, Giovanni Fm
dc.contributor.authorVernooij, Robin Wm
dc.contributor.authorWoodward, Mark
dc.contributor.authorde Wit, G Ardine
dc.contributor.authorBots, Michiel L
dc.date.accessioned2020-08-16T16:30:00Z
dc.date.available2020-08-16T16:30:00Z
dc.date.issued2020-02-05
dc.identifier.issn2044-6055
dc.identifier.pmid32029487
dc.identifier.doi10.1136/bmjopen-2019-033228
dc.identifier.urihttp://hdl.handle.net/10029/624124
dc.language.isoenen_US
dc.subjectend-stage kidney diseaseen_US
dc.subjecthaemodiafiltrationen_US
dc.subjecthaemodialysisen_US
dc.subjectprotocolen_US
dc.subjectrandomised controlled trialen_US
dc.titleBenefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.en_US
dc.typeArticleen_US
dc.identifier.journalBMJ Open 2020; 10(2):e033228en_US
dc.source.journaltitleBMJ open


This item appears in the following Collection(s)

Show simple item record